Survival Impact of Postoperative Whole-brain Radiotherapy and Systemic Chemotherapy After Surgical Resection of Brain Metastases
Authors:
- 26 July 2024
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 44 (8) , 3663-3667
Abstract
Background/Aim: Resection of brain metastases is a well-established treatment modality that can prolong the survival of patients for whom surgery is indicated. Whole-brain radiotherapy (WBRT) has been the standard postoperative therapy. In recent years, however, clinicians have increasingly avoided WBRT due to its associated adverse events. This study investigated the impact of postoperative WBRT and systemic chemotherapy as prognostic factors on the survival of patients who had undergone resection of brain metastases. Patients and Methods: The study subjects were 172 patients who underwent surgical resection for brain metastases. Comparative analyses of survival after WBRT and systemic chemotherapy were performed. Results: Postoperative WBRT had no survival-prolonging effect, whereas postoperative systemic chemotherapy prolonged survival. A comparison based on the number of systemic chemotherapy regimens administered prior to surgery showed that fewer regimens correlated with a better prognosis. Conclusion: The addition of WBRT after surgical resection of brain metastases is no longer a standard treatment strategy and systemic chemotherapy after surgery is a positive prognostic factor.Keywords
This publication has 14 references indexed in Scilit:
- Update on the Management of Brain MetastasisNeurotherapeutics, 2022
- Treatment for Brain Metastases: ASCO-SNO-ASTRO GuidelineJournal of Clinical Oncology, 2022
- Prognostic Factors for Patients With Brain Metastases Treated With Single-fraction Gamma Knife RadiosurgeryAnticancer Research, 2021
- Clinical Outcomes of Surgical Resection for Brain Metastases from Non-small Cell Lung CancerAnticancer Research, 2020
- Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled TrialJournal of Clinical Oncology, 2018
- Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trialThe Lancet Oncology, 2017
- Estimating Survival in Patients With Lung Cancer and Brain MetastasesJAMA Oncology, 2017
- Brain Tumor Registry of Japan (2005-2008)Neurologia medico-chirurgica, 2017
- Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain MetastasesJAMA, 2016
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010